Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

No longer available × patritumab deruxtecan × Thoracic × Clear all

Status

Recruiting 4 Active not recruiting 4 No longer available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Epidermal Growth Factor Receptor (EGFR)-Mutated Non Small Cell Lung Cancer 1

Interventions

tazemetostat 1 taletrectinib 1 rovalpituzumab tesirine 1 rociletinib 1 pegilodecakin 1 patritumab deruxtecan 1 osimertinib 1 lorlatinib 1 dabrafenib 1 ceritinib 1 capmatinib 1 brigatinib 1 alectinib 1 Suspensions 1 Powders 1 Paclitaxel 1 Nivolumab 1 BID protein, human 1 AM0010 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06099639 2025-06-08

Medical Access Program for Patritumab Deruxtecan

Daiichi Sankyo

No longer available

Epidermal Growth Factor Receptor (EGFR)-Mutated Non Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡